first
describ
macrophag
differenti
marker
mrna
accumul
murin
myeloleukem
cell
upon
activ
human
map
chromosom
contain
five
exon
cdna
human
encod
amino
acid
form
kda
protein
murin
map
chromosom
also
five
exon
cdna
encod
amino
acid
form
protein
protein
includ
death
domain
dd
receptor
tir
domain
similar
intracellular
domain
tlr
member
superfamili
collect
refer
tir
receptor
human
map
chromosom
contain
exon
cdna
human
encod
amino
acid
form
kda
protein
murin
gene
map
chromosom
also
contain
exon
correspond
cdna
encod
amino
acid
form
kda
protein
protein
contain
dd
central
kinas
domain
essenti
signal
via
tlr
except
extent
signal
via
includ
follow
activ
bind
tlr
via
tir
domain
form
oligom
recruit
receptor
via
dd
mediat
activ
variou
transcript
factor
includ
depend
part
cell
type
cell
surfac
receptor
stimul
fig
thu
signal
appear
import
innat
recognit
pathogen
ignit
inflamm
indispens
induct
protect
immun
howev
demonstr
import
pathway
protect
immun
base
studi
experiment
infect
mice
protect
immun
broad
rang
infecti
agent
shown
howev
essenti
natur
role
tir
signal
immun
call
question
clinic
genet
evolutionari
genet
studi
particular
identif
human
defici
immunolog
clinic
phenocopi
provid
consider
insight
detail
immunolog
clinic
descript
larg
cohort
patient
defici
led
reassess
import
pathway
gener
protect
immun
human
natur
condit
mice
known
suscept
experiment
infect
pathogen
bacteria
eight
virus
seven
protozoa
four
fungi
enhanc
pathogen
growth
mice
observ
six
bacteria
bacillu
anthraci
spore
inject
subcutan
sc
listeria
monocytogen
iv
ip
inject
infect
via
gavag
staphylococcu
aureu
iv
sc
inject
streptococcu
agalactica
sc
ip
inject
streptococcu
pneumonia
iv
infect
streptococcu
pyogen
sc
inject
eighteen
bacteria
anaplasmatacea
ip
inject
borrelia
burgdorferi
intraderm
id
inocul
borrelia
hermsii
ip
inject
brucella
abortu
ip
inject
burkholderia
pseudomallei
inocul
campylobact
jejunii
stomach
gavag
chlamydia
muridarum
inocul
chlamydia
pneumonia
applic
citrobact
koseri
direct
inocul
live
bacteria
brain
parenchyma
stereotact
inject
citrobact
rodentium
ingest
suspens
bacterium
gavag
franciscella
tularensi
inocul
id
deposit
haemophilu
influenza
inocul
ip
inject
klebsiella
pneumonia
intratrach
inocul
legionella
pneumonia
exposur
aerosol
inocul
mycoplasma
pneumonia
inocul
neisseria
meningitidi
ip
inject
pseudomona
aeruginosa
exposur
aerosol
bacteria
inocul
salmonella
typhimurium
iv
inject
three
mycobacteria
iv
aerogen
exposur
mycobacterium
avium
mycobacterium
bovi
mycobacterium
tuberculosi
eight
virus
herp
simplex
viru
type
aerogen
exposur
herp
simplex
viru
type
vagin
challeng
influenza
viru
inocul
lymphocyt
choriomening
viru
iv
inject
murin
cytomegaloviru
ip
inject
rabi
viru
intracrani
inject
sar
coronaviru
inocul
vesicular
stomat
viru
inocul
iv
inject
seven
parasit
cryptosporidium
parvum
gavag
enterocytozoon
bieneusi
oral
inocul
leishmania
braziliensi
sc
inject
promastigot
leishmania
major
sc
inject
promastigot
toxoplasma
gondii
ip
inject
trypanosoma
brucei
ip
infect
trypanosoma
cruzii
ip
inject
four
fungi
aspergillu
iv
infect
candida
albican
iv
intragastr
inject
cryptococcu
neoforman
inocul
ip
inject
paracoccidioid
brasiliensi
inocul
see
tabl
mice
show
enhanc
pathogen
growth
challeng
aureu
ip
greater
pathogen
growth
vivo
alway
correl
lower
level
surviv
consid
publish
mortal
data
experiment
infect
mice
mortal
due
experiment
infect
greater
mice
mice
pathogen
six
bacteria
b
anthraci
ip
inject
toxin
l
monocytogen
iv
inject
aureu
iv
inject
agalactica
sc
ip
inject
pneumonia
iv
infect
pyogen
sc
inject
eight
bacteria
anaplasmatacea
ip
inject
b
hermsii
ip
inject
b
pseudomallei
inocul
c
muridarum
inocul
c
pneumonia
applic
f
tularensi
inocul
id
deposit
k
pneumonia
inocul
p
aeruginosa
exposur
aerosol
bacteria
inocul
three
mycobacteria
iv
aerogen
exposur
avium
bovi
tuberculosi
eight
virus
herp
simplex
viru
type
aerogen
exposur
herp
simplex
viru
type
vagin
challeng
influenza
viru
inocul
lymphocyt
choriomening
viru
iv
inject
murin
cytomegaloviru
ip
inject
rabi
viru
intracrani
inject
sar
coronaviru
inocul
vesicular
stomat
viru
inocul
iv
inject
four
parasit
c
parvum
gavag
gondii
ip
inject
brucei
ip
infect
cruzii
ip
inject
four
fungi
aspergillu
iv
infect
c
albican
iv
intragastr
inject
c
neoforman
inocul
ip
inject
p
brasiliensi
inocul
see
tabl
mice
display
lower
level
surviv
mice
follow
ip
challeng
aureu
initi
descript
human
defici
base
three
patient
human
defici
base
nine
patient
patient
carri
either
homozyg
compound
heterozyg
mutat
gene
lead
nonfunct
protein
given
small
number
patient
brief
preliminari
conclus
could
made
concern
infecti
phenotyp
associ
absenc
signal
cumul
evid
larg
number
case
report
sinc
publish
comprehens
descript
cohort
patient
defici
defici
allow
firmer
conclus
infecti
phenotyp
absenc
signal
drawn
also
addit
five
patient
defici
two
patient
defici
data
yet
publish
infecti
patient
domin
invas
pyogen
infect
frequent
infect
mening
sepsi
arthriti
osteomyel
princip
bacteria
isol
case
invas
infect
pneumonia
aureu
pseudmomona
aeruginosa
list
pathogen
isol
patient
see
tabl
patient
also
typic
suffer
deep
tissu
infect
upper
respiratori
tract
sever
tonsil
due
p
aeruginosa
particular
superfici
skin
infect
mostli
caus
aureu
rule
possibl
predomin
bacteria
patient
defici
result
least
part
patient
recruit
bia
patient
defici
yet
identifi
indian
subcontin
south
america
china
patient
area
world
might
perhap
present
higher
frequenc
infect
bacteria
suggest
case
report
invas
infect
shigella
spp
endem
diarrhea
outbreak
howev
contrast
uncertainti
concern
posit
associ
infecti
phenotyp
highlight
much
emphat
neg
associ
drawn
concern
role
host
defens
patient
identifi
date
expos
mycobacteria
virus
toxoplasma
pneumocysti
fungi
none
pathogen
caus
invas
infect
strongli
suggest
dispens
human
defens
pathogen
contrari
expect
base
result
obtain
mous
model
time
write
patient
defici
identifi
publish
two
unpublish
von
bernuth
unpublish
nine
patient
die
sinc
identif
five
infanc
four
earli
childhood
youngest
nine
patient
die
month
age
oldest
die
year
age
surviv
patient
current
four
seven
year
old
patient
defici
identifi
patient
die
sinc
identif
infanc
earli
childhood
youngest
patient
month
old
oldest
year
old
time
death
latter
patient
larg
cohort
publish
recent
die
pneumonia
mening
unpublish
observ
surviv
patient
current
two
two
patient
three
one
patient
four
one
patient
five
two
patient
six
two
patient
seven
three
patient
nine
one
patient
one
patient
two
patient
two
patient
two
patient
two
patient
two
patient
one
patient
one
patient
one
patient
one
patient
one
patient
two
patient
one
patient
year
old
thu
clearli
seen
human
life
threaten
indispens
surviv
infanc
earli
childhood
advent
vaccin
antibiot
children
defect
would
die
first
year
life
howev
sever
individu
defici
immunolog
phenocopi
given
antibiot
prophylaxi
even
sometim
igg
substitut
follow
genet
identif
diseas
surviv
adolesc
adulthood
mani
patient
sinc
stop
take
regular
antibiot
prophylaxi
yet
develop
invas
pyogen
infect
signal
therefor
appear
dispens
surviv
adolesc
notion
innat
immun
recognit
indispens
surviv
protect
defens
mani
pathogen
base
larg
find
mous
model
experiment
infect
reconsid
light
natur
occur
infect
human
contrast
broad
suscept
mice
differ
bacteria
virus
protozoa
fungi
ie
almost
nearli
microb
test
patient
suscept
invas
noninvas
infect
bacteria
moreov
tlr
immun
undoubtedli
vital
infanc
earli
childhood
gradual
becom
dispens
adolesc
onward
overal
tlr
immun
vital
mice
human
role
cours
natur
occur
infect
human
seem
much
restrict
initi
infer
experiment
infect
mice
human
lack
function
protein
suscept
narrow
rang
pathogen
infanc
earli
childhood
differ
outcom
experiment
infect
mice
natur
infect
human
may
due
differ
like
differ
mode
infect
regard
studi
natur
occur
infect
mice
would
insight
suggest
preliminari
studi
case
studi
human
neatli
illustr
valu
dissect
inborn
error
immun
underli
pediatr
infecti
diseas
deciph
redund
nonredund
role
host
defens
gene
natura
immunolog
redund
greater
cours
natur
infect
outbr
human
popul
cours
experiment
infect
inbr
mice
genet
studi
type
facilit
burgeon
investig
contribut
immun
health
diseas
human
author
declar
conflict
interest
